Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

© Synapse Social LLC, 2026

Política de privacidad

A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults | Synapse

June 1, 2005Open Access

A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

The zoster vaccine markedly reduced morbidity from herpes zoster and postherpetic neuralgia among older adults.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Oxman et al. (Wed,) studied this question.

synapsesocial.com/papers/69d9a35aa1d151c65f684b30 https://doi.org/https://doi.org/10.1056/nejmoa051016

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Decline in Varicella‐Zoster Virus (VZV)–Specific Cell‐Mediated Immunity with Increasing Age and Boosting with a High‐Dose VZV Vaccine2003 · 320 citations
2Selective decline in cellular immune response to varicella‐zoster in the elderly1980 · 286 citations
3Clinical manifestations of herpes zoster2000 · 53 citations
4Reduction in burden of illness: A new efficacy measure for prevention trials1994 · 51 citations
5The sequelae of herpes zoster1997 · 14 citations